Background The pathophysiology of brain injury following aneurysmal subarachnoid
haemorrhage (SAH) is associated with numerous mediators. The aim of the study is to …

Background: Cognitive impairment commonly occurs in aneurysmal subarachnoid
hemorrhage (aSAH) survivors. Cerebrospinal fluid (CSF) biomarkers have been proven …

Subarachnoid hemorrhage (SAH) is a devastating neurological injury associated with
significant patient morbidity and death. Since the first demonstration of cerebral vasospasm …

Aneurysmal subarachnoid hemorrhage is a devastating condition, often leading to a
debilitating outcome. Delayed ischemic neurological deficits are considered the feared …

Aneurysmal subarachnoid hemorrhage (aSAH) is a devastating neurological disease. It has
many sequelae, including vasospasm and delayed ischemic neurological deficits (DINDs) …

Background Proteomic analysis of cerebrospinal fluid (CSF) has shown great promise in
identifying potential markers of injury in neurodegenerative diseases 1, 2, 3, 4, 5, 6, 7, 8, 9 …

Background The complexity of the inflammatory response post subarachnoid hemorrhage
(SAH) may require temporal analysis of multiple protein biomarkers simultaneously to be …

Background Subarachnoid bleeding is associated with brain injuries and ranges from
almost negligible to acute and life threatening. The main objectives were to study changes in …

Poor outcomes of aneurysmal subarachnoid hemorrhage (aSAH) can be the result of the
initial catastrophic event or the many acute or delayed neurological complications. Recent …

Background Analysis of cerebrospinal fluid (CSF) using mass spectrometry is a relatively
novel analytical tool, and comparisons of ventricular and cisternal proteomes are yet to be …